Mohammad Khalil: Evaluating DAPT Duration after Percutaneous Coronary Intervention
Mohammad Khalil, Bachelor of Medicine at Royal College of Surgeons in Ireland (RCSI), shared a post on LinkedIn about a recent article he and Yahia Khalil co-authored, published in Cureus Journal of Medical Science, adding:
“I am pleased to share the publication of my latest research article in Cureus Journal of Medical Science:
Short- Versus Standard-Duration Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
This publication marks my first as the lead (first) author, representing a significant milestone in my academic and research journey.
In this systematic review and meta-analysis of 23,586 patients across seven randomized controlled trials, we evaluated the safety and efficacy of abbreviated dual antiplatelet therapy following PCI in patients with acute coronary syndrome.
Our findings demonstrate that shorter-duration DAPT significantly reduces major bleeding without increasing overall major adverse cardiovascular events, while highlighting the importance of selecting an appropriate P2Y12 inhibitor for maintaining ischemic safety.”
Title: Short- Versus Standard-Duration Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
Authors: Mohammad Khalil, Yahia Khalil

Stay updated 0n all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience